市場調查報告書

荷爾蒙置換療法市場規模,佔有率,趨勢分析:各產品,各給藥途徑,各疾病類型,各地區,各市場區隔預測

Hormone Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Estrogen, Human Growth), By Route Of Administration (Oral, Parenteral), By Type Of Disease, By Region, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 930827
出版日期 內容資訊 英文 100 Pages
商品交期: 2-3個工作天內
價格
荷爾蒙置換療法市場規模,佔有率,趨勢分析:各產品,各給藥途徑,各疾病類型,各地區,各市場區隔預測 Hormone Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Estrogen, Human Growth), By Route Of Administration (Oral, Parenteral), By Type Of Disease, By Region, And Segment Forecasts, 2020 - 2027
出版日期: 2020年03月18日內容資訊: 英文 100 Pages
簡介

全球荷爾蒙置換療法市場至2027年預測將以年複合成長率7.7%擴大,並達到396億美元的規模。新生兒,成人,老年人的荷爾蒙障礙的發病率上升帶動市場擴大。在2019年的收益點雌激素置換療法市場區隔獨佔了整體市場。同時由於荷爾蒙障礙的發病數增加,預計2020∼2027年非口服市場區隔將迅速發展。

本報告提供全球荷爾蒙置換療法市場相關調查,市場趨勢與預測,市場規模,主要加入企業,各地區趨勢相關資訊彙整。

第1章 調查方法與調查範圍

第2章 摘要整理

第3章 市場變數,趨勢,範圍

  • 市場區隔
  • 滲透、成長預測製圖
    • 促進要素分析
    • 阻礙要素分析
  • 商務環境分析工具
    • 波特五力分析
    • PESTEL分析

第4章 各產品分析

  • 市場佔有率分析
  • 市場區隔概要
  • 各產品區隔市場規模,預測,趨勢
    • 雌激素荷爾蒙置換療法
    • HGH置換療法
    • 甲狀腺荷爾蒙置換療法
    • 睪固酮荷爾蒙置換療法

第5章 各給藥途徑分析

  • 市場佔有率分析
  • 市場區隔概要
  • 各產品區隔市場規模,預測,趨勢
    • 口服
    • 非口服
    • 經皮
    • 其他

第6章 各疾病類型分析

  • 市場佔有率分析
  • 市場區隔概要
  • 各產品區隔市場規模,預測,趨勢
    • 更年期
    • 甲狀腺機能低下症
    • 男性性腺功能低下症
    • 生長激素缺乏症
    • 其他

第7章 各地區分析

  • 各地區市場佔有率
  • 市場區隔概要
  • 各地區市場概要
  • 市場規模,預測,趨勢
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲

第8章 競爭分析

  • 策略性架構、競爭分類
  • 供應商環境
  • 企業的市場地位分析
  • 企業簡介
    • Abbott Laboratories
    • Novartis
    • Pfizer
    • Mylan Laboratories
    • Merck & Co.
    • Amgen
    • Novo Nordisk
    • Bayer
    • Eli Lilly
    • Genentech
目錄
Product Code: 978-1-68038-784-1

The global hormone replacement therapy market size is expected to reach USD 39.6 billion by 2027, expanding at a CAGR of 7.7%, according to a new report by Grand View Research, Inc. A significant rise in the incidence rate of hormonal disorders in the newborns, adults, and elderly and populations is driving the market. The Prader-Willi syndrome (PWS) affects one in every 15,000 newborns, thereby boosting the demand for the therapy.

Estrogen replacement hormone therapy helps in reducing the vaginal indications of menopause, such as dryness, burning, itching, and pain during intercourse. Estrogen is available in the forms of pill, gel, skin patch, cream or spray form. It is highly successful for treating problematic menopausal night sweats and hot flashes. Around 45% of women between the ages of 40 to 60 years of age were reported taking counseling sessions from a physician regarding the advantages and disadvantages of using hormone replacement therapy (HRT) after menopause.

Growing awareness about menopausal signs and the treatment options is growing the HRT market. Owing to the significant development for ERT, there has been an initiation of very safe treatment options for the patients situated in various geographies of the world. For example, augmentation of innovative drug delivery systems like transdermal estrogen patches and vaginal estrogen drugs.

Further key findings from the report suggest:

The estrogen replacement therapy segment dominated the overall market in terms of revenue share in the year 2019. On the other hand, the parenteral segment is likely to showcase the fastest growth rate over the forecast period from 2020 to 2027, owing to the rising number of hormonal disorders

Menopause is likely to showcase the fastest growth rate over the forecast period. Women are vulnerable to certain diseases and conditions such as osteoporosis and hot flashes during and after menopause. About 73% of postmenopausal women suffer from hot flashes

North America dominated the overall hormone replacement therapy market in terms of revenue share in the year 2019. The increase in the incidence rate of hypogonadism due to a rise in obesity and poor health in the geriatric population drive the market. According to the American Academy of Family Physicians, more than 2.5 million Americans received testosterone treatment in U.S alone in 2014

Some of the key players in this market are Abbott Laboratories; Novartis; Pfizer, Inc.; Mylan Laboratories; Merck and Co.; Novo Nordisk; Bayer Healthcare; Eli Lilly; and Genentech.

Table of Contents

Chapter Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Product
    • 1.1.2 Route of Administration
    • 1.1.3 Type of Disease
    • 1.1.4 Regional Scope
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity flow analysis (Model 1)
    • 1.6.2 Volume price analysis (Model 2)
  • 1.7 List of Secondary Sources
  • 1.8 Objectives
    • 1.8.1 Objective - 1
    • 1.8.2 Objective - 2

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
    • 2.2.1 Product
    • 2.2.2 Route of Administration
    • 2.2.3 Type of Disease
    • 2.2.4 Region
  • 2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Penetration & Growth Prospect Mapping
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
  • 3.3 Hormone Replacement Therapy Market: Business Environment Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
      • 3.3.1.1 Bargaining power of suppliers
      • 3.3.1.2 Bargaining power of buyers
      • 3.3.1.3 Threat of new entrants
      • 3.3.1.4 Competitive rivalry
      • 3.3.1.5 Threat of substitutes
    • 3.3.2 PESTEL Analysis
      • 3.3.2.1 Political & legal
      • 3.3.2.2 Economic
      • 3.3.2.3 Technological

Chapter 4 Hormone Replacement Therapy Market: Product Analysis

  • 4.1 Hormone Replacement Therapy Product Market Share Analysis, 2019 & 2027
  • 4.2 Hormone Replacement Therapy Product Market: Segment Dashboard
  • 4.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Product Segment
    • 4.3.1 Estrogen Hormone Replacement Therapy
      • 4.3.1.1 Estrogen Hormone replacement therapy market, 2016 - 2027 (USD Million)
    • 4.3.2 HGH Replacement Therapy
      • 4.3.2.1 HGH replacement therapy market, 2016 - 2027 (USD Million)
    • 4.3.3 Thyroid Hormone Replacement Therapy
      • 4.3.3.1 Thyroid hormone replacement therapy market, 2016 - 2027 (USD Million)
    • 4.3.4 Testosterone Hormone Replacement Therapy
      • 4.3.4.1 Testosterone hormone replacement therapy market, 2016 - 2027 (USD Million)

Chapter 5 Hormone Replacement Therapy Market: Route of Administration Analysis

  • 5.1 Hormone Replacement Therapy Route of Administration Market Share Analysis, 2019 & 2027
  • 5.2 Hormone Replacement Therapy Route of Administration Market: Segment Dashboard
  • 5.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Route of Administration Segment
    • 5.3.1 Oral
      • 5.3.1.1 Oral market, 2016 - 2027 (USD Million)
    • 5.3.2 Parenteral
      • 5.3.2.1 Parenteral market, 2016 - 2027 (USD Million)
    • 5.3.3 Transdermal
      • 5.3.3.1 Transdermal market, 2016 - 2027 (USD Million)
    • 5.3.4 Others
      • 5.3.4.1 Others market, 2016 - 2027 (USD Million)

Chapter 6 Hormone Replacement Therapy Market: Type of Disease Analysis

  • 6.1 Hormone Replacement Therapy Type of Disease Market Share Analysis, 2019 & 2027
  • 6.2 Hormone Replacement Therapy Type of Disease Market: Segment Dashboard
  • 6.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Type of Disease Segment
    • 6.3.1 Menopause
      • 6.3.1.1 Menopause market, 2016 - 2027 (USD Million)
    • 6.3.2 Hypothyroidism
      • 6.3.2.1 Hypothyroidism market, 2016 - 2027 (USD Million)
    • 6.3.3 Male Hypogonadism
      • 6.3.3.1 Male hypogonadism market, 2016 - 2027 (USD Million)
    • 6.3.4 Growth Hormone Deficiency
      • 6.3.4.1 Growth hormone deficiency market, 2016 - 2027 (USD Million)
    • 6.3.5 Others
      • 6.3.5.1 Others market, 2016 - 2027 (USD Million)

Chapter 7 Hormone Replacement Therapy Market: Regional Analysis

  • 7.1 Hormone Replacement Therapy Regional Market Share Analysis, 2019 & 2027
  • 7.2 Hormone Replacement Therapy Regional Market: Segment Dashboard
  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
  • 7.4 Market Size, & Forecasts, and Trend Analysis, 2016 to 2027
    • 7.4.1 North America
      • 7.4.1.1 North America hormone replacement therapy market, 2016 - 2027 (USD Million)
      • 7.4.1.1.1 U.S.
      • 7.4.1.1.1.1 U.S. hormone replacement therapy market, 2016 - 2027 (USD Million)
      • 7.4.1.1.2 Canada
      • 7.4.1.1.2.1 Canada hormone replacement therapy market, 2016 - 2027 (USD Million)
    • 7.4.2 Europe
      • 7.4.2.1 Europe Hormone Replacement Therapy market, 2016 - 2027 (USD Million)
      • 7.4.2.1.1 U.K.
      • 7.4.2.1.1.1 U.K. hormone replacement therapy market, 2016 - 2027 (USD Million)
      • 7.4.2.1.2 Germany
      • 7.4.2.1.2.1 Germany hormone replacement therapy market, 2016 - 2027 (USD Million)
    • 7.4.3 Asia Pacific
      • 7.4.3.1 Asia Pacific hormone replacement therapy market, 2016 - 2027 (USD Million)
      • 7.4.3.1.1 Japan
      • 7.4.3.1.1.1 Japan hormone replacement therapy market, 2016 - 2027 (USD Million)
      • 7.4.3.1.2 China
      • 7.4.3.1.2.1 China hormone replacement therapy market, 2016 - 2027 (USD Million)
    • 7.4.4 Latin America
      • 7.4.4.1 Latin America hormone replacement therapy market, 2016 - 2027 (USD Million)
      • 7.4.4.1.1 Brazil
      • 7.4.4.1.1.1 Brazil hormone replacement therapy market, 2016 - 2027 (USD Million)
      • 7.4.4.1.2 Mexico
      • 7.4.4.1.2.1 Mexico hormone replacement therapy market, 2016 - 2027 (USD Million)
    • 7.4.5 Middle East and Africa (MEA)
      • 7.4.5.1 MEA hormone replacement therapy market, 2016 - 2027 (USD Million)
      • 7.4.5.1.1 South Africa
      • 7.4.5.1.1.1 South Africa hormone replacement therapy market, 2016 - 2027 (USD Million)
      • 7.4.5.1.2 Saudi Arabia
      • 7.4.5.1.2.1 Saudi Arabia hormone replacement therapy market, 2016 - 2027 (USD Million)

Chapter 8 Competitive Analysis

  • 8.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
  • 8.2 Vendor Landscape
  • 8.3 Company market position analysis (Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)
  • 8.4 Company Profiles
    • 8.4.1 Abbott Laboratories
      • 8.4.1.1 Company overview
      • 8.4.1.2 Financial performance
      • 8.4.1.3 Product benchmarking
      • 8.4.1.4 Strategic initiatives
    • 8.4.2 Novartis
      • 8.4.2.1 Company overview
      • 8.4.2.2 Financial performance
      • 8.4.2.3 Product benchmarking
      • 8.4.2.4 Strategic initiatives
    • 8.4.3 Pfizer
      • 8.4.3.1 Company overview
      • 8.4.3.2 Financial performance
      • 8.4.3.3 Product benchmarking
      • 8.4.3.4 Strategic initiatives
    • 8.4.4 Mylan Laboratories
      • 8.4.4.1 Company overview
      • 8.4.4.2 Financial performance
      • 8.4.4.3 Product benchmarking
      • 8.4.4.4 Strategic initiatives
    • 8.4.5 Merck & Co.
      • 8.4.5.1 Company overview
      • 8.4.5.2 Financial performance
      • 8.4.5.3 Product benchmarking
      • 8.4.5.4 Strategic initiatives
    • 8.4.6 Amgen
      • 8.4.6.1 Company overview
      • 8.4.6.2 Financial performance
      • 8.4.6.3 Product benchmarking
      • 8.4.6.4 Strategic initiatives
    • 8.4.7 Novo Nordisk
      • 8.4.7.1 Company overview
      • 8.4.7.2 Financial performance
      • 8.4.7.3 Product benchmarking
      • 8.4.7.4 Strategic initiatives
    • 8.4.8 Bayer
      • 8.4.8.1 Company overview
      • 8.4.8.2 Financial performance
      • 8.4.8.3 Product benchmarking
      • 8.4.8.4 Strategic initiatives
    • 8.4.9 Eli Lilly
      • 8.4.9.1 Company overview
      • 8.4.9.2 Financial performance
      • 8.4.9.3 Product benchmarking
      • 8.4.9.4 Strategic initiatives
    • 8.4.10 Genentech
      • 8.4.10.1 Company overview
      • 8.4.10.2 Financial performance
      • 8.4.10.3 Product benchmarking
      • 8.4.10.4 Strategic initiatives

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 North America hormone replacement therapy market, by region, 2016 - 2027 (USD Million)
  • TABLE 3 North America hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
  • TABLE 4 North America hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
  • TABLE 5 North America hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
  • TABLE 6 U.S. hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
  • TABLE 7 U.S. hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
  • TABLE 8 U.S. hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
  • TABLE 9 Canada hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
  • TABLE 10 Canada hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
  • TABLE 11 Canada hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
  • TABLE 12 Europe hormone replacement therapy market, by region, 2016 - 2027 (USD Million)
  • TABLE 13 Europe hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
  • TABLE 14 Europe hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
  • TABLE 15 Europe hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
  • TABLE 16 U.K. hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
  • TABLE 17 U.K. hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
  • TABLE 18 U.K. hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
  • TABLE 19 Germany hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
  • TABLE 20 Germany hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
  • TABLE 21 Germany hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
  • TABLE 22 Asia Pacific hormone replacement therapy market, by region, 2016 - 2027 (USD Million)
  • TABLE 23 Asia Pacific hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
  • TABLE 24 Asia Pacific hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
  • TABLE 25 Asia Pacific hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
  • TABLE 26 Japan hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
  • TABLE 27 Japan hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
  • TABLE 28 Japan hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
  • TABLE 29 China hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
  • TABLE 30 China hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
  • TABLE 31 China hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
  • TABLE 32 Latin America hormone replacement therapy market, by region, 2016 - 2027 (USD Million)
  • TABLE 33 Latin America hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
  • TABLE 34 Latin America hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
  • TABLE 35 Latin America hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
  • TABLE 36 Brazil hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
  • TABLE 37 Brazil hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
  • TABLE 38 Brazil hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
  • TABLE 39 Mexico hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
  • TABLE 40 Mexico hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
  • TABLE 41 Mexicohormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
  • TABLE 42 MEA hormone replacement therapy market, by region, 2016 - 2027 (USD Million)
  • TABLE 43 MEA hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
  • TABLE 44 MEA hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
  • TABLE 45 MEA hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
  • TABLE 46 South Africa hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
  • TABLE 47 South Africa hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
  • TABLE 48 South Africa hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
  • TABLE 49 Saudi Arabia hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
  • TABLE 50 Saudi Arabia hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
  • TABLE 51 Saudi Arabia hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market formulation & validation
  • FIG. 8 Hormone replacement therapy market outlook, 2019
  • FIG. 9 Market trends & outlook
  • FIG. 10 Hormone replacement therapy market segmentation
  • FIG. 11 Penetration & growth prospect mapping
  • FIG. 12 Market driver relevance analysis (Current & future impact)
  • FIG. 13 Market restraint relevance analysis (Current & future impact)
  • FIG. 14 Global hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 15 Hormone replacement therapy: Market dynamics
  • FIG. 16 Global geriatric population, 2012 - 2022 (Million)
  • FIG. 17 Percentage of geriatric population in European countries, 2014
  • FIG. 18 Opportunity analysis, by product
  • FIG. 19 Hormone replacement therapy market - Porter's analysis
  • FIG. 20 Hormone replacement therapy market - PESTEL analysis
  • FIG. 21 Global hormone replacement therapy market share, by product, 2016 & 2027
  • FIG. 22 Estrogen hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 23 Human growth hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 24 Thyroid hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 25 Testosterone hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 26 Global hormone replacement therapy market share, by route of administration, 2016 & 2027
  • FIG. 27 Oral hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 28 Parenteral hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 29 Transdermal hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 30 Other route of administration hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 31 Global hormone replacement therapy market share, by type of disease, 2016 & 2027
  • FIG. 32 Menopause market, 2016 - 2027 (USD Million)
  • FIG. 33 Hypothyroidism market, 2016 - 2027 (USD Million)
  • FIG. 34 Male hypogonadism market, 2016 - 2027 (USD Million)
  • FIG. 35 Growth hormone deficiency market, 2016 - 2027 (USD Million)
  • FIG. 36 Others market, 2016 - 2027 (USD Million)
  • FIG. 37 Hormone replacement therapy market share, by region, 2016 & 2027
  • FIG. 38 North America hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 39 U.S. hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 40 Canada hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 41 Europe hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 42 U.K. hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 43 Germany hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 44 Asia Pacific hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 45 Japan hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 46 China hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 47 Latin America hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 48 Brazil hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 49 Mexico hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 50 MEA hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 51 South Africa hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 52 Saudi Arabia hormone replacement therapy market, 2016 - 2027 (USD Million)
  • FIG. 53 Strategy framework
  • FIG. 54 Hormone replacement therapy competitive landscape: Market position analysis (based on products, regional presence, and recent updates (2019))